Influence of ginsenoside combined with temozolomide on the levels of HGF, TNF-α, and IL-17 in cerebrospinal fluid of postoperative patients with brain glioma

WU Bin; XIA Liang; FENG Fang; SUN Cai-xing

您当前的位置：

首页 >

文章列表页 >

Influence of ginsenoside combined with temozolomide on the levels of HGF, TNF-α, and IL-17 in cerebrospinal fluid of postoperative patients with brain glioma

更新时间：2022-08-31

- Influence of ginsenoside combined with temozolomide on the levels of HGF, TNF-α, and IL-17 in cerebrospinal fluid of postoperative patients with brain glioma
- Shanghai Journal of Traditional Chinese Medicine Vol. 51, Issue 1, Pages: 50-52(2017)
- 作者机构：
  
  1. 浙江省肿瘤医院神经外科,浙江,杭州,310022
- 作者简介：
- 基金信息：
- DOI：
  CLC：
扫描看全文
WU Bin, XIA Liang, FENG Fang, et al. Influence of ginsenoside combined with temozolomide on the levels of HGF, TNF-α, and IL-17 in cerebrospinal fluid of postoperative patients with brain glioma. [J]. Shanghai Journal of Traditional Chinese Medicine 51(1):50-52(2017)
DOI：

WU Bin, XIA Liang, FENG Fang, et al. Influence of ginsenoside combined with temozolomide on the levels of HGF, TNF-α, and IL-17 in cerebrospinal fluid of postoperative patients with brain glioma. [J]. Shanghai Journal of Traditional Chinese Medicine 51(1):50-52(2017) DOI：

摘要

目的：观察人参皂苷联合替莫唑胺治疗脑胶质瘤术后患者的临床疗效及其对脑脊液干细胞生长因子(HGF)、TNF-α、IL-17水平的影响。方法：将90例脑胶质瘤术后患者随机分为试验组和对照组,各45例；对照组给予替莫唑胺治疗,试验组在对照组基础上口服人参皂苷Rg3,疗程为6个治疗周期。比较两组总生存期(OS)、无进展生存时间(PFS)及治疗前后脑脊液HGF、TNF-α、IL-17的水平变化。结果：治疗后,试验组OS和PFS显著长于对照组(P<0.05)；治疗后,两组患者脑脊液HGF、TNF-α、IL-17水平较治疗前均显著降低(P<0.05,P<0.01),且试验组HGF、TNF-α、IL-17水平显著低于对照组(P<0.05)。结论：人参皂苷Rg3联合替莫唑胺可抑制脑胶质瘤的生长增殖而延长患者生存期。

Abstract

Objective:To observe the clinical efficacy and influence of ginsenoside combined with temozolomide on the levels of HGF, TNF-α and IL-17 in cerebrospinal fluid of postoperative patients with brain glioma. Methods90 postoperative patients with brain glioma were divided into the treatment group and the control group,45 cases in each group. The control group was treated with temozolomide, the treatment group was treated with ginsenoside Rg3 based on the treatment for control group,with a course of 6 treatment cycles. The overall survival (OS), progression-free survival (PFS), and the levels of HGF, TNF-α and IL-17 in cerebrospinal fluid before and after treatment were compared. Results:After treatment,the OS and PFS in the treatment group were significantly longer than those in the control group (P<0.05); after treatment,the levels of HGF, TNF-α and IL-17 in cerebrospinal fluid of patients in both groups were significantly decreased compared with the treatment before(P<0.05, P<0.01), and the levels of HGF, TNF-α and IL-17 in the treatment group were significantly lower than those in the control group(P<0.05). Conclusion:Ginsenoside Rg3 combined with the temozolomide can inhibit the growth and proliferation of brain glioma and prolong the survival time of patients.

关键词

脑胶质瘤人参皂苷干细胞生长因子

Keywords

brain gliomaginsenosidestem cell factor

references

Views

164

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research progress on analytic determination methods of ginsenosides

Related Author

No data

Related Institution

School Hospital,Jilin Agriculture University

Laboratory of Quality and Safety Risk Assessment for Ginseng and Antler Products,Ministry of Agriculture,Jilin Agricultural University

⁰